The Therapeutic Momentum podcast series illuminates the inspiring personal stories, touchstone moments, and transformational events that fuel the relentless pursuit of life-changing treatments. It reveals the intricate tapestry of experiences that drive people in the biomedical field who share the collective goal of improving patient outcomes. We hope to offer listeners a multifaceted perspective on the diverse talent and backgrounds of people working towards better health and hope for patients.

Andy Plump discusses his journey from a postdoc at UCSF to a leading roles in pharmaceutical research. Andy, who joined Merck in 2001, worked in clinical pharmacology. He highlighted the importance of genetics in target selection and shares his experiences at Sanofi and Takeda, emphasizing the cultural sensitivities and leadership lessons gained from global experiences. The interview explores the transformative potential of AI and machine learning in biopharmaceutical research.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

Coronary heart disease is no longer a mystery. Listen to the story of one of medicine’s greatest triumphs — a battle fought in labs, clinics, kitchens, and boardrooms. This is the story of cholesterol. And how we turned a silent killer into a preventable disease.